106 related articles for article (PubMed ID: 20684155)
1. Six patients with early-stage cutaneous T-cell lymphoma successfully treated with topical 5-fluorouracil.
Kannangara AP; Levitan D; Fleischer AB
J Drugs Dermatol; 2010 Aug; 9(8):1017-8. PubMed ID: 20684155
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
Kannangara AP; Levitan D; Fleischer AB
J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
[TBL] [Abstract][Full Text] [Related]
3. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
4. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
[TBL] [Abstract][Full Text] [Related]
5. Metallic taste as a side effect of topical fluorouracil use.
Han SY; Youker S
J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
[TBL] [Abstract][Full Text] [Related]
8. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
Martin AG
J Drugs Dermatol; 2003 Apr; 2(2):155-67. PubMed ID: 12852367
[TBL] [Abstract][Full Text] [Related]
9. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.
Whittaker SJ; Demierre MF; Kim EJ; Rook AH; Lerner A; Duvic M; Scarisbrick J; Reddy S; Robak T; Becker JC; Samtsov A; McCulloch W; Kim YH
J Clin Oncol; 2010 Oct; 28(29):4485-91. PubMed ID: 20697094
[TBL] [Abstract][Full Text] [Related]
10. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.
Mann BS; Johnson JR; Cohen MH; Justice R; Pazdur R
Oncologist; 2007 Oct; 12(10):1247-52. PubMed ID: 17962618
[TBL] [Abstract][Full Text] [Related]
11. A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.
Duvic M; Olsen EA; Omura GA; Maize JC; Vonderheid EC; Elmets CA; Shupack JL; Demierre MF; Kuzel TM; Sanders DY
J Am Acad Dermatol; 2001 Jun; 44(6):940-7. PubMed ID: 11369904
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
Tsimberidou AM; Giles FJ; Duvic M; Kurzrock R
J Am Acad Dermatol; 2004 Aug; 51(2):200-4. PubMed ID: 15280837
[TBL] [Abstract][Full Text] [Related]
13. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma.
Wollina U; Dummer R; Brockmeyer NH; Konrad H; Busch JO; Kaatz M; Knopf B; Koch HJ; Hauschild A
Cancer; 2003 Sep; 98(5):993-1001. PubMed ID: 12942567
[TBL] [Abstract][Full Text] [Related]
14. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant.
Heald PW; Glusac EJ
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):283-5. PubMed ID: 10642687
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.
Graham BD; Jetmore AB; Foote JE; Arnold LK
Dis Colon Rectum; 2005 Mar; 48(3):444-50. PubMed ID: 15747068
[TBL] [Abstract][Full Text] [Related]
16. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
Olsen EA; Kim YH; Kuzel TM; Pacheco TR; Foss FM; Parker S; Frankel SR; Chen C; Ricker JL; Arduino JM; Duvic M
J Clin Oncol; 2007 Jul; 25(21):3109-15. PubMed ID: 17577020
[TBL] [Abstract][Full Text] [Related]
17. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of early cutaneous T-cell lymphoma.
Ramsay DL; Meller JA; Zackheim HS
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma.
Takahashi H; Funabiki K; Hasebe S; Fukuda-Yamamoto T; Kaieda S; Iwanaga T; Kumagami H; Takasaki K
Auris Nasus Larynx; 2005 Dec; 32(4):353-7. PubMed ID: 16039816
[TBL] [Abstract][Full Text] [Related]
20. Treatment of superficial ulcerative squamous cell carcinoma in three horses with topical 5-fluorouracil.
Paterson S
Vet Rec; 1997 Dec; 141(24):626-8. PubMed ID: 9447676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
